Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,405.22 -33.43 (-0.40%) Bitcoin USD
66,373.02 +186.53 (+0.28%) CMC Crypto 200
1,351.36 -22.48 (-1.64%)
Dr. Reddy's Laboratories Limited (DRREDDY.NS)
NSE - NSE Real-time price. Currency in INR
Add to watchlist
At close: 03:30PM IST
Currency in INR
Valuation measures4
| Market cap (intra-day) | 972.60B |
| Enterprise value | 908.77B |
| Trailing P/E | 17.49 |
| Forward P/E | 20.33 |
| PEG ratio (5-yr expected) | 3.53 |
| Price/sales (ttm) | 3.49 |
| Price/book (mrq) | 3.45 |
| Enterprise value/revenue | 3.26 |
| Enterprise value/EBITDA | 10.28 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.34 |
| 52-week change 3 | 33.21% |
| S&P500 52-week change 3 | 26.36% |
| 52-week high 3 | 6,505.90 |
| 52-week low 3 | 4,384.05 |
| 50-day moving average 3 | 6,136.69 |
| 200-day moving average 3 | 5,850.49 |
Share statistics
| Avg vol (3-month) 3 | 370.2k |
| Avg vol (10-day) 3 | 457.44k |
| Shares outstanding 5 | 166.53M |
| Implied shares outstanding 6 | 167.15M |
| Float 8 | 119.75M |
| % held by insiders 1 | 8.30% |
| % held by institutions 1 | 67.27% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 40 |
| Forward annual dividend yield 4 | 0.68% |
| Trailing annual dividend rate 3 | 40.00 |
| Trailing annual dividend yield 3 | 0.68% |
| 5-year average dividend yield 4 | 0.62 |
| Payout ratio 4 | 11.95% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 15 Jul 2024 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 28 Aug 2006 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2024 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 19.95% |
| Operating margin (ttm) | 20.87% |
Management effectiveness
| Return on assets (ttm) | 11.67% |
| Return on equity (ttm) | 21.77% |
Income statement
| Revenue (ttm) | 279.16B |
| Revenue per share (ttm) | 1,677.72 |
| Quarterly revenue growth (yoy) | 12.50% |
| Gross profit (ttm) | N/A |
| EBITDA | 81.05B |
| Net income avi to common (ttm) | 55.68B |
| Diluted EPS (ttm) | 334.64 |
| Quarterly earnings growth (yoy) | 36.30% |
Balance sheet
| Total cash (mrq) | 81.47B |
| Total cash per share (mrq) | 489.26 |
| Total debt (mrq) | 20.02B |
| Total debt/equity (mrq) | 7.14% |
| Current ratio (mrq) | 2.58 |
| Book value per share (mrq) | 1,684.80 |
Cash flow statement
| Operating cash flow (ttm) | 45.43B |
| Levered free cash flow (ttm) | 15.07B |
© 2024 Yahoo. All rights reserved.